Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) SHH

Currency In CNY

AD

Valuation

Market Cap12.06B
Enterprise Value10.05B
P/E Ratio17.07
PEG Ratio2.8
Price/Sales Ratio2.6
Price/Book Ratio2.3
Enterprise/Revenue2.5
Enterprise/EBITDA12.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.15
Operating Margin0.18
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.14

Income Statement

Revenue3.87B
Revenue/Share9.12
Gross Profit1.9B
EBITDA810.78M
Net Income581.49M
Diluted EPS1.35

Balance Sheet

Total Cash2.51B
Total Cash/Share5.82
Total Debt225.89M
Total Debt/Equity0.05
Current Ratio3.52
Book Value Per Share10.71

Price History

52-Week Change-15.82
52-Week High30.18
52-Week Low21.22
Moving Average 50 Days23.01
Moving Average 200 Days24.71

Statistics

Average Volume5.03M
Shares Outstanding431.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.7
Trailing Annual Dividend Yield2.95
Payout Ratio0
Last Split Factor13:10
Last Split DateJuly 21, 2015
AD